CD8A and neoplasm: Thus, tumor-exposed PGC-1α-overexpressing CD8 T cells are able to maintain their mitochondrial content/activity, and this programmed metabolic advantage bestows them with more robust re-expansion capacity in response to antigen recall in a tumor-free microenvironment.